Often in routine tests, Complete Blood Count or Haemogram is tested which gives an indication if an individual is suffering from Anaemia. Anaemia is a less understood condition
by the masses and involves a battery of tests to reveal the underlying condition. Anaemia could either be due to nutritional deficiencies, abnormal red blood cells or any other conditions like liver or kidney disorder that could lead to iron deficiency. Tests like Transferrin Saturation and TIBC (which is one of the many tests in serum iron studies) is used to assess iron deficiency or overload.
Transferrins are iron-binding blood plasma glycoproteins that control the level of free iron in biological fluids. The liver is the main site of transferrin synthesis, but other tissues and organs, such as the brain, also produce it. The main role of transferrin is to deliver iron from absorption centers in the duodenum and white blood cell macrophages to all tissues. Transferrin Saturation almost always is measured along with Total Iron Binding Capacity. The results of these two tests give complete information on anaemia.
Transferrin saturation, abbreviated as TSAT and measured as a percentage is the ratio of serum iron and total iron-binding capacity, multiplied by 100.
Global & National Quality Accreditations – CAP (USA) and NABL , Govt. of India.
Guaranteed error free diagnosis.
Bar Coded and automated process. No room for manual errors.
Specific normal range for Indian population built from 33 years of experience.
Sample collection from home/office.
Metropolis: Experience + Expertise
Over the past 3 decades we have earned the respect of doctors and patients. Today we conduct over 30 million tests annually with accuracy each year. Our repertoire extends over 4500 tests and over 100 different technologies. Our customer care is available round the clock for any queries that you may have.
Save tax on the Preventive health check-ups up to Rs. 5000, under section 80D of Income Tax Act, 1961
We are Metropolis - Your Pathology Specialist
Metropolis is one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). With operations across India, Africa, South Asia and Middle East.
Our globally accredited clinical laboratories deliver accurate and timely test results. We offer a comprehensive range of clinical laboratory tests and profiles which are used in prediction, early detection, diagnostic screening, confirmation and monitoring of diseases.
Delivering diagnostic services since 1980
Network of 100+ clinical labs & 1100+ patient touch points
Qualified team of phlebotomists for Home collection services
Certified NABL and CAP accredited labs
Wide range of 4000+ tests & profiles
Convenience of home collection service
Metropolis Healthcare Limited is proposing subject to applicable statutory or regulatory requirements, receipt of requisite approvals, market conditions and other considerations to undertake an initial public offering of its equity shares and has filed a draft red herring prospectus dated September 27, 2018 (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of the SEBI at www.sebi.gov.in, BSE Limited at www.bseindia.com, National Stock Exchange of India Limited at www.nseindia.com and the websites of Book Running Lead Managers at www.jmfl.com, www.credit-suisse.com, www.investmentbank.kotak.com, www.hdfcbank.com and www.goldmansachs.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to same, please refer to the DRHP including the section “Risk Factors” of the DRHP. Potential investors should not rely on the DRHP filed with the SEBI for making any investment decision.